Hutch News
Results per Page:
A promising HIV vaccine candidate gets a little help
New strategy stirs a robust response from T cells tracked by McElrath lab
Infectious disease scientists look beyond the pandemic
A symposium about protecting people with weakened immune systems from microbial threats
Early research may show new way to block dengue and Zika virus
Scientists find different flavor of broadly neutralizing antibody that could lead to new vaccines for growing threat
Peripheral neuropathy: When having no pain is a big problem
Chemotherapy-induced nerve damage is common for cancer patients and difficult to treat
Two rare antibodies, one drug, four viruses
Researchers discover antibodies to block RSV, other viruses that put transplant patients at risk
Dr. Fred Appelbaum receives Lifetime Achievement award
Medical pioneer and longtime Fred Hutch leader honored by American Society for Transplantation and Cellular Therapy
How blood cancer research might help organ transplant patients
Fred Hutch study suggests certain immune cells are source of antibodies that attack donated organs
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
Could a 100-year-old TB vaccine help scientists find a better one?
Harmless vaccine BCG is made of living bacteria; in tests might serve as a proxy for deadly tuberculosis
On World AIDS Day, a broad view of continuing work
Teams of Fred Hutch scientists test vaccines, treatments, new strategies
Dr. Larry Corey receives Alexander Fleming Award
Virologist honored by peers for his lifetime achievements against infectious diseases
Researching herpes treatments with 'skin-on-chip' technology
Experimental device grows human skin, infects and treats it; could advance disease modeling in labs
Fred Hutch hosts inaugural Dr. E. Donnall Thomas Symposium
Event draws leading researchers in transplantation, gene and cell therapy
Researchers refine experimental gene therapy for herpes
Treatment sharply reduced viral shedding in laboratory mice
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation
NIAID director’s determined spirit recognized with honorary Hutch Award
Dispatches from the microbial frontier of cancer research
Hutch scientists aim high by way of the lowly microorganisms that call us home
Researchers advance development of potential Epstein-Barr virus vaccines
Stakes raised as common virus linked to more diseases
Test of a new 'germline-targeting' HIV vaccine prepares to launch
Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus
Solid tumors use a type of T cell as a shield against immune attack
Discovery in head and neck cancers may open door for targeted immune-boosting drugs
Dr. Phil Greenberg becomes president-elect of American Association for Cancer Research
Immunologist looks ahead to international leadership role